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was evaluated in 60 patients with baseline normal renal functionA modern approach to selectivity of proteinuria and tubuloin-
(serum creatinine 0.97 6 0.19 mg/dL). The patients with high,terstitial damage in nephrotic syndrome.
moderate, or nonselective proteinuria had 100, 50, and 29%Background. The selectivity of proteinuria, introduced in
of complete or partial remission (P 5 0.0001) and 0, 25, andclinical nephrology in 1960 and useful in predicting steroid
35% of progression to CRF, respectively (P 5 0.050). In 45responsiveness in nephrotic syndrome, found little place in
patients with moderately selective (N 5 28) and nonselectiveclinical practice in subsequent decades, since its assessment did
(N 5 17) proteinuria, according to some arbitrary cutoffs fornot appear to help predict histologic diagnosis or determine
FE a1m (MGN, # vs. . 0.240% of creatinine clearance; FSGSprognosis. The amount of proteinuria and the degree of tubulo-
and MCD, # vs. . 0.350%), the remission rate was 62 versusinterstitial damage appeared to be better predictors of func-
6% in patients with FE a1m below or above the cutoffs (P 5tional outcome. A correlation between them has been found,
0.0001), and progression to CRF was 7 and 69%, respectivelyreferred to some toxicity of proteinuria on tubular cells, but
(P 5 0.0001). The response to therapy (complete or partialso far no single feature or component of proteinuria has been
remission at the last observation), evaluated retrospectivelyidentified as being responsible for this toxicity.
in 40 patients, was 100, 67, and 33% in high, moderate, andMethods. We evaluated 89 patients with nephrotic syndrome
nonselective proteinuria (P 5 0.0002); in 30 patients with mod-[9 with minimal change disease (MCD), 29 with primary focal
erate and nonselective proteinuria, according to an FE a1msegmental glomerulosclerosis (FSGS), and 51 with idiopathic
value that was # or . the cutoffs, the response rate was 75membranous glomerulonephritis (MGN)] to determine if the
versus 10% (P 5 0.001).selectivity of proteinuria was associated with tubulointerstitial
Conclusions. There is a significant relationship between se-damage. A semiquantitative grading of histologic lesions and
lectivity of proteinuria and tubulointerstitial damage. More-qualitative evaluation of the “tubular” component of protein-
over, the selectivity of proteinuria has a predictive value onuria expressed as a pattern of sodium dodecyl sulfate-polyacryl-
functional outcome. When proteinuria is highly selective, theamide gel electrophoresis (SDS-PAGE) and as fractional
tubulointerstitial damage is rather infrequent, and 100% ofexcretion of the low molecular weight (LMW) protein a1-
patients develop clinical remission. When proteinuria is moder-microglobulin (FE a1m) were used. A second aim of the study
ately selective or nonselective, increasing numbers of patientswas to assess the predictive value on functional outcome [remis-
develop tubulointerstitial damage; in these patients, the func-sion or progression to chronic renal failure (CRF)] and re-
tional outcome and response to therapy is partly dependentsponse to therapy of the selectivity of proteinuria, considered
on tubulointerstitial involvement, and the best predictor ofalone and in combination with FE a1m.
functional outcome is the combination of SI and FE a1m.Results. Proteinuria was classified as highly selective [selec-
tivity index (SI) # 0.10, N 5 15], moderately selective (SI $
0.11 # 0.20, N 5 34), or nonselective (SI $ 0.21, N 5 40).
A significant relationship was found between the SI and the The concept of selectivity of proteinuria was intro-
histologic degree of tubulointerstitial damage (score 0 to 1 vs. duced by Blainey et al in 1960 [1], and its value in pre-
score $2, P 5 0.000), severity of the tubular component of
dicting the response to steroid therapy in nephrotic syn-proteinuria (mixed SDS-PAGE pattern with LMW proteins
drome was established in both adults [2] and childrennot lower than 23 kD vs. mixed pattern with LMW proteins
up to 20 to 10 kD, P 5 0.000), and FE a1m (values below vs. [3]. The assessment of selectivity of proteinuria was sim-
above a defined cut-off, P 5 0.000). The functional outcome plified by Cameron and Blandford in 1966 with the intro-
duction of the selectivity index (SI) [4]. In subsequent
decades, the selectivity of proteinuria found little placeKey words: selectivity index, chronic renal failure, toxicity, focal seg-
in clinical practice, since its assessment did not appear tomental glomerulosclerosis, idiopathic membranous glomerulonephri-
tis, lesions, a1-microglobulin. help in predicting histologic diagnosis or in determining
prognosis. Recently, some authors suggested that thisReceived for publication June 7, 1999
opinion should be reconsidered. In a study of 52 patientsand in revised form March 29, 2000
Accepted for publication April 25, 2000 with focal segmental glomerulosclerosis (FSGS), mini-
mal change disease (MCD), and IgM nephropathy, LaurentÓ 2000 by the International Society of Nephrology
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Table 1. Clinical characteristics of patientset al showed that the predictive value of SI on response
to therapy was much higher than that of histologic type MGN FSGS MCD
[5]. In membranous glomerulonephritis (MGN), Mallick, N 51 29 9
Mean age years 54614 42618 34617Short, and Manos showed that patients whose protein-
Sex m/f 31/20 17/12 5/4uria had remitted had a SI lower than 0.19, whereas
CRF % 25% 10% 0%
the majority of patients whose proteinuria persisted had ARF % 0% 10% 0%
24-hour P g/day 7.163.1 10.066.7 8.267.0unselective proteinuria [6]. A study by Tencer et al
showed that SI, calculated as a ratio of clearance of a2- Definitions are: CRF, chronic renal failure; serum creatinine irreversibly .1.4
mg/dL; ARF, acute renal failure; serum creatinine transiently .1.4 mg/dL.macroglobulin (a2m) or IgM to that of albumin, can be Abbreviations are: MGN, membranous glomerulonephritis; FSGS, focal seg-
useful in identifying histologic diagnosis, at least in MCD mental glomerulosclerosis; MCD, minimal change disease.
and crescentic necrotizing glomerulonephritis (GN) [7].
The data accumulated in the last two decades in most
forms of primary GN showed that the amount of protein-
to 248); all of these 28 patients had persistent nephroticuria and the degree of tubulointerstitial damage are the
syndrome at the time of the study of proteinuria [22 withmain predictors for progression to chronic renal failure
normal renal function (NRF) and 6 with CRF].(CRF) [8–16]. The amount of proteinuria is a reliable
Nephrotic syndrome was defined as proteinuria $3.5indicator of the severity of the abnormality of glomerular
g/day and serum albumin #3.0 g/dL. NRF was definedpermeability and is also related to tubulointerstitial dam-
as serum creatinine (SCr) #1.4 mg/dL. CRF was definedage, as shown in several experimental models [8] and in
as SCr irreversibly .1.4 mg/dL, and acute renal failuresome human GN [17, 18], probably because of an intrin-
(ARF) was defined as SCr transiently .1.4 mg/dL.sic toxicity of proteinuria on tubular cells [14]. Although
Fifty-one patients were diagnosed with idiopathica tubulotoxicity of some proteins, such as albumin and
MGN, 38 with NRF (SCr 0.99 6 0.21 mg/dL) and 13 withtransferrin [19, 20], has been suggested, in human dis-
CRF (SCr 2.63 6 1.44 mg/dL). Twenty-nine patients hadeases, no single urinary protein or characteristic of pro-
primary FSGS, 23 with NRF (SCr 1.03 6 0.19 mg/dL),teinuria has been so far identified as being responsible
3 with acute reversible impairment of renal function (SCrfor tubular damage.
1.70 6 0.14 mg/dL), and 3 with CRF (SCr 1.89 6 0.34The aim of our study was to re-evaluate the clinical
mg/dL). Nine patients had MCD, all with NRF (SCrsignificance of selectivity of proteinuria in patients with
0.83 6 0.15 mg/dL).nephrotic syndrome caused by some types of primary
The functional outcomes were defined as follows: com-GN (MCD, FSGS, and MGN) to assess whether there
plete remission, 24-hour proteinuria ,0.2 g/day withis a relationship between the SI and tubulointerstitial
NRF and inactive urinary sediment; partial clinical re-damage using three methods: semiquantitative grading
mission, proteinuria ,2.0 g/day with NRF; persistentof tubulointerstitial lesions in biopsy specimens, qualita-
non-nephrotic proteinuria, proteinuria .2.0 and ,3.5tive characterization of the “tubular” component of pro-
g/day, with NRF; persistent nephrotic syndrome, pro-teinuria by sodium dodecyl sulfate-polyacrylamide gel
teinuria persistently $3.5 g/day with NRF; progressionelectrophoresis (SDS-PAGE), and calculation of frac-
to CRF, end-stage renal disease (ESRD), or doublingtional excretion of a1m. A second aim of our study was
of SCr.to assess the predictive value on functional outcome and
response to therapy of SI, considered alone and in combi-
Methodsnation with a marker of tubular damage, such as the
For each patient, a 24-hour urine collection and afractional excretion of a1 microglobulin (FE a1m).
second morning urine sample were obtained. Total uri-
nary proteins were measured by the Coomassie Blue
METHODS method and were expressed in grams per 24 hours. Serum
Patients and urinary creatinine were measured automatically on
Hitachi 717 instrument (Boehringer, Mannheim, Ger-Eighty-nine patients with a diagnosis of nephrotic syn-
many) by the Jaffe` method without deproteinization,drome were included in the study; some of their clinical
and were expressed in mg/dL and in mg/L, respectively.features are reported in Table 1. Sixty-one were new
patients with a histologic diagnosis of MCD, FSGS, and
Selectivity indexMGN, assessed in our unit by renal biopsy from January
Serum and urinary (in second morning urine samples)1992 to December 1998; these patients performed renal
IgG and transferrin were measured by an immunoneph-biopsy and characterization of proteinuria at the same
elometric method on a BNA nephelometer (Behring,time. Twenty-eight patients had a renal biopsy per-
Milan, Italy) using rabbit sera anti-human IgG and trans-formed in our unit before 1992 and characterization of
proteinuria 62 6 67 months after renal biopsy (range 1 ferrin (Behring, Milan, Italy). The SI was calculated ac-
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cording to the Cameron and Blandford method [4] using clearance) and FSGS and MCD (FE a1m # vs. .
0.350%), taking into account the different values of 24-this formula:
hour proteinuria in MGN (7.1 6 3.1 g/day) and in FSGS
and MCD (10.0 6 6.7 g/day and 8.2 6 7.0 g/day, respec-SI 5
uIgG
sIgG
3
sTf
uTf tively; Table 1) and the competition between high and
LMW proteins for tubular reabsorption. To verifyProteinuria was considered highly selective if the SI was
whether the choice of the FE a1m cutoffs was correct,#0.10, moderately selective if the SI was $0.11 and
a receiver operating characteristic (ROC) analysis was#0.20, and nonselective if the SI was $0.21.
subsequently performed for MGN and FSGS patients.
In MGN, the FE a1m value that best discriminated theFractional excretion of a1-microglobulin
patients for both remission and progression was 0.233%For the evaluation of the reabsorption impairment of
(remission, sensitivity 87%, specificity 53%; progression,microproteins by tubular cells, a1m (molecular mass 31.8
sensitivity 87%, specificity 87%). In FSGS, the valuekD) was chosen because its measurement in urine is not
that best discriminated remission was #0.350 (sensitivitydependent upon urinary pH, as it is for b2-microglobulin,
100%; specificity 64%); the value that best discriminatedand it is easily measured by automated methods. Serum
progression was .0.200 (sensitivity 100%; specificityand urinary (in second morning urine samples) a1m were
62%), but the value chosen in our study (.0.350) hadmeasured by an immunonephelometric method on a
similar sensitivity and specificity values (80 and 81%).BNA nephelometer. To prepare the calibration curves,
we used the N Protein Standard UY (Dade Behring, Renal biopsies
Marburg GMbH, Germany), in which the concentration
Renal biopsies were performed and evaluated by pre-was obtained by the manufacturer by reference to highly
viously published standard histologic and immunofluo-purified proteins and an earlier protein standard prepa-
rescence methods [22]. A semiquantitative evaluation ofration of Dade Behring Marburg GMbH. The method
some histologic parameters was performed in 61 patientsused was not able to distinguish the free from the bound
at the same time as their renal biopsy and characteriza-form of a1m. tion of proteinuria. The percentage of globally sclerosedThe FE of a1m, expressed as a percentage of creatinine glomeruli was obtained by dividing the number of scle-clearance, was calculated according to this formula:
rosed glomeruli by the total number of glomeruli and
multiplying by 100. The patients with global glomerularua1m
sa1m
3
sCr
uCr
3 100
sclerosis ,10% were compared with the patients with
glomerular sclerosis $10%. The extent of the tubuloin-
To evaluate whether the FE a1m is an effective marker terstitial changes was evaluated according to the method
of the tubular reabsorption impairment of microglobu- of Ridson, Sloper and de Wardener [23]. Ten consecutive
lins, we compared the mean fractional excretions of IgG, microscopic fields of the cortex of each biopsy sample
transferrin, and a1m in all patients. FE transferrin was were examined with a 340 objective. A field was graded
0.37 6 0.44% of creatinine clearance; FE IgG was 0.12 6 0 if there was no tubular atrophy and 1 or 2 if tubular
0.24%, and FE a1m was 0.62 6 1.39%. Thus, the frac- atrophy was focal or diffuse. In a similar fashion, intersti-
tional excretion values of a1m were markedly higher tial fibrosis and/or infiltration were graded 0, 1, or 2 if
than that of IgG, suggesting that the FE a1m reflects the absent, focal, or diffuse, respectively. The tubular and
excretion of a low molecular weight (LMW) protein, interstitial scores obtained were summed to obtain a
because the fractional excretion of IgA-a1m complexes single score for the tubulointerstitial damage, which was
(P.M. ,190 kD) should be lower than the fractional then classified as follows: 0 or 1, lesions absent or very
excretion of IgG. Moreover, FE a1m was significantly mildly focal; 2, focal tubular and interstitial lesions; and
associated (P 5 0.000) with the SDS-PAGE patterns that 3 or 4, diffuse lesions. Patients with score 0 to 1 were
we demonstrated to be associated with tubulointerstitial compared with patients with a score of $2. Subintimal
damage (Results section) [21]. Finally, FE a1m was also hyalinosis [arteriolar hyalinosis (AH)] was graded 0, 1,
significantly associated with the extension of tubulointer- or 2 if absent, focal, or diffuse, respectively. The patients
stitial damage (P 5 0.02) that was evaluated semiquanti- without AH were compared with patients with focal or
tatively (Results section). Taken together, these data diffuse AH.
suggest that the FE a1m is an effective marker of tubular
SDS-PAGEreabsorption impairment of microglobulins because of
tubular damage. The SDS-PAGE was performed as previously de-
To divide patients into two groups with “low” or scribed [23]. Four main patterns were identified in GN:
“high” FE a1m, two different cut-off values were chosen (1) physiologic pattern (albumin alone); (2) pure glomer-
ular pattern [only middle and high molecular weightfor MGN (FE a1m # vs. . 0.240 3 100 mL of creatinine
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Table 3. Clinical and laboratory features at baseline of patients withTable 2. Distribution of the selectivity index among the
patients studied highly, moderately or nonselective proteinuria
SI#0.10 SI$0.11#0.20 SI$0.21Selectivity All patients MGN FSGS MCD
index (89) (51) (29) (9)
N 15 34 40
SCr mg/dL 0.836012ab 0.9960.23ab 1.6961.07a#0.10 15 (17%) 7 (14%) 2 (7%) 6 (67%)
$0.11#0.20 34 (38%) 23 (45%) 9 (31%) 2 (22%) 24-hour P g/day 7.765.6c 6.965.0c 9.464.7c
FE a1m 0.15760.088d 0.19860.147d 1.15861.954d$0.21 40 (45%) 21 (41%) 18 (62%) 1 (11%)
NRF % 100% 94% 55%Definitions are: SI # 0.10, highly selective proteinuria; SI $ 0.11 # 0.20,
moderately selective proteinuria; SI $ 0.21, nonselective proteinuria. NRF (normal renal function) is defined as SCr # 1.4 mg/dL.
Abbreviations are: HS, high selectivity; MS, moderate selectivity; NS, nonse-
lectivity.
a NS vs. MS and HS, P 5 0.000; b NS vs. MS, P 5 NS; c HS vs. MS vs. NS, P 5
NS; d NS vs. MS and HS, P 5 0.002
proteins (MMW and HMW), such as albumin, transferrin
and immunoglobulins]; (3) mixed glomerulotubular pat-
tern with HMW, MMW, and LMW proteins with molec- Table 4. Relationship between selectivity index, tubulointerstitial
ular weight between 69 and 23 kD (pattern termed 23 damage, SDS-PAGE proteinuric patterns, and fractional
excretion of a1mkD); and (4) a mixed glomerulotubular pattern with
HMW, MMW, and LMW proteins up to 20 to 10 kD SDS-PAGE
TID score pattern FE a1m(pattern termed 10 kD). The pure glomerular pattern
0–1 $2 23 kD 10 kD ,cut-offs .cut-offswas rather infrequent in nephrotic syndrome. The preva-
lent patterns were the mixed ones. The physiologic pat- SI#0.10 85% 15% 87% 13% 87% 13%
SI$0.11#0.20 83% 17% 64% 36% 76% 24%tern was observed only in patients with a complete remis-
SI$0.21 28% 72% 17% 83% 30% 70%sion of proteinuria. P value 0.000 0.000 0.000
TID (tubulointerstitial damage) is defined as score 0–1 vs. score $ 2 (MethodsStatistical methods
section). SDS-PAGE pattern is 23 kD mixed glomerulotubular pattern vs. 10
kD mixed glomerulotubular pattern (see Methods). FE a1m (fractional excretionData were expressed as mean values 6 SD. The sig-
of a1-microglobulin) cut offs are: MGN, # vs. . 0.240% of creatinine clearance;nificance of differences between proportions was tested FSGS and MCD, # vs. . 0.350% of creatinine clearance. Statistical test is by
chi-square with Bonferroni correction.by the chi-square test. The Bonferroni correction was
applied. The receiver operating characteristic (ROC)
analysis was performed according to Zweig and Camp-
bell [24]. To evaluate the differences in the rates of (45%), and nonselective proteinuria in FSGS (62%)
outcomes, statistical methods appropriate for the analy- (Table 2). SCr was significantly higher in patients with
sis of censored data were used [25], since the duration of nonselective proteinuria (1.69 6 1.07 mg/dL) in compari-
patient follow-up was not uniform. Proteinuric variables son with patients with highly selective (SCr 0.83 6 0.12
were tested individually or in combination for prognostic mg/dL) and moderately selective proteinuria (SCr 0.99 6
significance using time of entry to CRF or remission as 0.23 mg/dL, P 5 0.000; Table 3). Twenty-four hour pro-
the measure of outcome. The cumulative survival curves teinuria was not significantly different between the three
were derived by the Kaplan–Meier method [26]. The groups of selectivity (high selectivity, P 5 7.7 6 5.6 g/day;
equality of survival curves obtained for different groups moderate selectivity, P 5 6.9 6 5.0 g/day; nonselectivity
of patients was assessed by the log-rank test. Differences 9.4 6 4.7 g/day, P 5 0.104). Fractional excretion of a1m
were considered significant with P value of less than 0.05 was significantly higher in patients with nonselective pro-
or less than 0.01 when the Bonferroni correction was teinuria versus patients with highly and moderately selec-
applied. tive proteinuria (P 5 0.002; Table 3). At baseline, impair-
ment of renal function was present in 0, 6, and 45% of
patients with highly selective, moderately selective, andRESULTS
nonselective proteinuria, respectively (Table 3).
Selectivity of proteinuria
SDS-PAGE patternsFifteen patients had highly selective proteinuria (mean
value 0.07 6 0.02; range 0.04 to 0.10; MCD 6, FSGS 2, The SDS-PAGE pattern was available in 84 patients
MGN 7; Table 2). Thirty-four patients had moderately and was distributed as follows: in highly selective protein-
selective proteinuria (mean value 0.15 6 0.02; range 0.11 uria, 87% showed the 23 kD pattern and 13% the 10 kD
to 0.20; MCD 2, FSGS 9, MGN 23). Forty patients had pattern (Table 4). In moderately selective proteinuria,
nonselective proteinuria (mean value 0.33 6 0.11; range 64% showed the 23 kD pattern and 36% the 10 kD
0.21 to 0.65; MCD 1, FSGS 18, MGN 21). The more pattern. In nonselective proteinuria, only 17% showed
frequent patterns were highly selective proteinuria in the 23 kD pattern, while 83% had the 10 kD pattern.
The differences were highly significant (P 5 0.000) evenMCD (67%), moderately selective proteinuria in MGN
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Table 5. Predictive value on functional outcome of selectivity indexif the statistical analysis was limited to patients with NRF
independently from histologic diagnosis in 60 patients with baseline
(P 5 0.000). normal renal function (SCr 0.97 6 0.19 mg/dL)
N Remission Progression to CRFTubulointerstitial lesions
SI#0.10 15 100% 0%A semiquantitative evaluation of histologic lesions was
SI$0.11#0.20 28 50% 25%
assessed in 61 patients in whom renal biopsy and charac- SI$0.21 17 29% 35%
P value 0.0001 0.050terization of proteinuria were performed at the same
time. Eighty-five percent of the patients with highly se- Remission is defined as complete (24-hour proteinuria , 0.2 g/day) or partial
(24-hour proteinuria , 2.0 g/day) remission of proteinuria with normal renallective proteinuria had a score of 0 to 1 and 15% a score
function.
of $2 (Table 4). Eighty-three percent of patients with Progression to CRF is defined as end-stage renal disease (ESRD) or doubling
of serum creatinine.moderately selective proteinuria had a score of 0 to 1
Statistical test is by log-rank test.
and 17% a score of $2. Twenty-eight percent of patients
with nonselective proteinuria had a score of 0 to 1, and
72% had a score of $2. The differences were highly
significant (P 5 0.000; P 5 0.001 in patients with NRF). proteinuria. Twenty-eight patients had moderately selec-
tive proteinuria, and 17 patients nonselective proteinuria.Global glomerular sclerosis (,10% vs. $10%) and AH
(absent vs. focal or diffuse) did not show a significant The “start-point” of the follow-up was the date of charac-
terization of proteinuria and the duration of follow-up wasrelationship with SI (global sclerosis, P 5 0.059; AH,
P 5 0.082). 37 6 22 months (range 6 to 84). The overall functional
outcome was complete and partial clinical remission (34
Fractional excretion of a1-microglobulin patients, 57%), persistent non-nephrotic proteinuria
with NRF (9 patients, 15%), persistent nephrotic syn-The FE a1m was calculated in all patients. The patients
were compared according to different cutoffs: FE a1m # drome with NRF (4 patients, 7%), progression to CRF
(13 patients, 22%: 11 ESRD; 2 doubling of SCr). Since 8or . 0.240% of creatinine clearance for MGN and FE
a1m # or . 0.350 for FSGS and MCD. In highly selective of these 60 patients performed the renal biopsy 88 6 55
months before the characterization of proteinuria andproteinuria, 87% of patients had values below the cut-
offs, and 13% had values above the cutoffs; in moder- had therefore a longer duration of disease, the statistical
analysis was repeated for the 52 patients who had theately selective proteinuria, the percentages were 76 and
24% (Table 4). In nonselective proteinuria, the percent- “start-point” of follow-up at renal biopsy.
ages were 30 and 70%. The differences were significant
Selectivity index alone(P 5 0.000; P 5 0.003 in patients with NRF). The statisti-
cal analysis was repeated separately for MGN and FSGS The overall functional outcome according to selectiv-
ity of proteinuria, irrespective of histologic diagnosis,patients (in MCD, only one patient had FE a1m above
the defined cutoff). In MGN in highly selective protein- was complete or partial clinical remission in 100, 50, and
29% of highly and moderately selective, and nonselectiveuria, 86% of the patients had values below the cutoff,
and 14% had values above the cutoff; in moderately proteinuria (P 5 0.0001; Table 5; Fig. 1) and progression
to CRF in 0, 25, and 35% of the same groups (P 5selective proteinuria, the percentages were 70 and 30%.
In nonselective proteinuria, the percentages were 14 and 0.050). Limiting the statistical analysis to 52 patients who
had the “start-point” of follow-up at renal biopsy remis-86%. The differences were significant (P 5 0.000). In
FSGS patients, the percentages were, respectively, 100 sion was 100, 58, and 38% (P 5 0.0001), and progression
was 0, 21, and 31% (P 5 0.050). Sensitivity and specificityand 0%, 89 and 11%, and 44 and 56% (P 5 0.04).
The FE a1m below or above the cutoff is also signifi- for remission were 44 and 100% for highly selective
proteinuria, 41 and 54% for moderately selective, 15cantly associated with SDS-PAGE patterns [“low” FE
a1m, 23 kD pattern (68%); 10 kD pattern (32%); “high” and 54% for nonselective proteinuria. Sensitivity and
specificity for progression to CRF were, respectively, 0FE a1m, 23 kD pattern (18%), 10 kD pattern (82%);
P 5 0.000] and with the extension of tubulointerstitial and 68% for high selectivity, 54 and 55% for moderate
selectivity, and 46 and 77% for nonselectivity.damage [low FE a1m, score 0 to 1 (70%), score $2
(30%); high FE a1m, score 0 to 1 (37.5%), score $2
Selectivity index plus fractional excretion(62.5%); P 5 0.02].
of a1-microglobulin
Predictive value on functional outcome In 15 patients with highly selective proteinuria, the
remission rate was 100% and the CRF rate was 0%.The functional outcome could be evaluated in 60 of
70 patients with baseline NRF (8 MCD, SCr 0.84 6 0.16 Among them, only two patients (13%) had FE a1m val-
ues above the cutoffs. In 28 patients with moderatelymg/dL; 21 FSGS, SCr 1.00 6 0.18 mg/dL; 31 MGN, SCr
0.99 6 0.18 mg/dL). Fifteen patients had highly selective selective and 17 patients with nonselective proteinuria
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Fig. 1. Probability of complete or partial re-
mission of the nephrotic syndrome according
to the selectivity index (SI # 0.10, 100%,
heavy line; SI $ 0.11, # 0.20, 50%, dashed
line; SI $ 0.21, 29%, dotted line) in 60 patients
with membranous glomerulonephritis (MGN;
N 5 31), focal and segmental glomerulosclero-
sis (FSGS; N 5 21), and minimal change dis-
ease (MCD; N 5 8) and baseline normal renal
function (NRF). Log rank test, P 5 0.0001.
Table 6. Predictive value on functional outcome of selectivity (50%), and the CRF rate was higher (25%). In nonselec-
index $ 0.11 in combination with FE a1m in 45 patients tive proteinuria, tubulointerstitial involvement was more(MCD 2, FSGS 19, MGN 24) with baseline normal renal
function (SCr 0.98 6 0.18 mg/dL) frequent (TID $2, 72%; 10 kD pattern 83%; FE a1m
above the cutoffs: 70%). The remission rate was lowN Remission Progression to CRF
(29%), and the CRF rate was rather high (35%). InSI$0.11, FE a1m,cut-offs 29 62% 7%
patients with moderately selective or nonselective pro-SI$0.11, FE a1m.cut-offs 16 6% 69%
P value 0.0001 0.0001 teinuria, the remission and progression rates were sig-
Statistical test is by the log-rank test. nificantly dependent on tubular damage evaluated by
FE a1m.
Response to therapy
(MGN 24, FSGS 19, MCD 2; baseline SCr 0.98 6
The response to therapy was evaluated retrospectively0.18 mg/dL; remission rate 42%; CRF rate 29%), using
in 40 patients (MCD 8, FSGS 21, MGN 11) with baselinethe arbitrarily defined cutoffs for FE a1m (Methods sec-
NRF (SCr 0.97 6 0.17 mg/dL). All patients were treatedtion), the remission rate was 62 vs. 6% in patients with
soon after the characterization of proteinuria. Ten pa-FE a1m below or above the cutoffs (P 5 0.0001; Table
tients were treated with steroids alone (starting dose 16 and Fig. 2; MGN, 53 vs. 11%, P 5 0.004; FSGS, 67
mg/kg/day; duration of therapy 4 to 10 months), and 30vs. 0%, P 5 0.010). The CRF rate in patients with FE
patients were treated with steroids and cyclophospha-a1m below or above the cutoffs was, respectively, 7 and
mide. Patients with MGN were treated with steroids and69% (P 5 0.0001; Table 6 and Fig. 3; MGN, 7 vs. 78%,
cyclophosphamide on alternate months for six monthsP 5 0.004; FSGS, 8 vs. 57%, P 5 0.020). Sensitivity and
according to the protocol of Ponticelli et al [27]. Patientsspecificity for remission in patients with FE a1m below
with MCD and FSGS were treated with steroids (startingthe cutoffs were 95 and 42%; in patients with FE a1m
dose 1 mg/kg/day) for 4 to 12 months and cyclophospha-above the cutoff sensitivity and specificity for progression
mide (1.5 to 2.0 mg/kg/day) for two to six months. Theto CRF were, respectively, 85 and 84%. Limiting the
response to therapy was considered the presence of com-analysis to 37 patients with the start-point of follow-up
plete or partial remission (Methods section) at the lastat renal biopsy remission was 67 versus 10% (P 5 0.002),
observation. The distribution of SI among treated pa-and progression was 7 versus 70% (P 5 0.0005).
tients was: SI #0.10, N 5 10 patients; SI $0.11 #0.20,In conclusion, in highly selective proteinuria, tubuloin-
N 5 18 patients; SI $0.21, N 5 12 patients. The response toterstitial damage was rather infrequent (TID $2, 15%,
therapy was 100, 67, and 33% in high, moderate, and non-10 kD pattern 13%; FE a1m $ cutoffs 13%). The remis-
selective proteinuria, respectively (P 5 0.0002; Table 7).sion rate was 100%. The functional outcome seemed
All patients except one with SI #0.10 had a FE a1mlargely dependent on the lesions of glomerular capillary
below the chosen cutoffs. In 30 patients with moderatelywall, which were mild and reversible. In moderately se-
selective and nonselective proteinuria, the response ratelective proteinuria, tubulointerstitial damage was more
was 75% in patients with FE a1m below the cutoffsfrequent (TID $2, 17%; 10 kD pattern 36%; FE a1m
above the cutoffs 24%). The remission rate was lower (MGN 83%, FSGS 67%) and 10% in patients with FE
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Fig. 2. Probability of complete or partial re-
mission in 45 patients with SI $ 0.11 according
to the fractional excretion of a1-microglobulin
(FE a1m) below (heavy line) or above (dotted
line) the cutoffs (MGN 24, FSGS 19, MCD
2). Log rank test, P 5 0.0001.
Fig. 3. Probability of maintaining NRF (no
ESRF or doubling of SCr) in 45 patients with
SI $ 0.11 according to FE a1m below (solid
line) or above (dashed line) the cutoffs.
Table 7. Response to therapy according to selectivity index alone DISCUSSION
and in combination with fractional excretion of a1m in 40 patients
(MCD 8, FSGS 21, MGN 11) with baseline normal renal function Some toxic effect of proteinuria on tubular epithelial
cells has been considered to be responsible for the tubu-N % Response P value
lointerstitial lesions that are frequently associated with
SI#10 10 100%
glomerular lesions in primary GN. Experimental studiesSI$0.11#0.20 18 67%
SI$0.21 12 33% 0.0002 showed that some constituents of proteinuria stimulate
SI$0.11#0.20 and $0.21 18/12 the production of inflammatory mediators and vaso-
FE a1m , cut-offs 20 75% active substances by tubular cells in culture. Rabbit prox-FW a1m . cut-offs 10 10% 0.001
imal tubular cells in culture, stimulated by IgG, showedResponse is defined as complete or partial remission (see Methods) at the
last observation. a significant dose-dependent increase of endothelin-1
Statistical test was log-rank test. synthesis, but this stimulatory effect was not specific to
IgG and was shared by albumin and transferrin [28].
Endothelin-1 synthesis by human tubular cells in culture
was also stimulated by human high-density lipoproteins
a1m above the cutoffs (P 5 0.001; MGN 33%, FSGS [29]. In human tubular cells cultures incubated with
0%; Table 7 and Fig. 4). urines containing microproteins with a molecular weight
In conclusion, the response rate was excellent (100%) lower than 28 kD (assessed by SDS-PAGE), we observed
in patients with highly selective proteinuria (all with FE a significant higher synthesis of monocyte chemoattrac-
a1m below the cutoffs except one). In patients with mod- tant protein-1 (MCP-1) than in cultures incubated with
erately selective and nonselective proteinuria, the re- urines containing microproteins with molecular weight
not lower than 40 kD (abstract; Li Min et al, Symposiumsponse rate was markedly influenced by the FE a1m.
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Fig. 4. Probability of response to therapy
(clinical remission) in 30 patients with SI $
0.11 according to FE a1m below (heavy line)
or above (dashed line) the cutoffs.
on “Renal tubular cells in culture,” Antwerp, Belgium, with nonselective proteinuria (P 5 0.0001). Progression
to CRF developed in 0% of patients with highly selective1998, p 18). In human diseases, no single urinary compo-
nent or characteristic of proteinuria thus far has been proteinuria, 25% of patients with moderately selective pro-
teinuria, and in 35% of patients with nonselective protein-identified as responsible for tubulointerstitial lesions.
The aim of our study was to re-evaluate the clinical uria (P 5 0.050). The combination of SI with the frac-
tional excretion of a1m greatly enhanced the predictivesignificance of selectivity of proteinuria, to assess its pos-
sible relationship with tubulointerstitial damage, and to value of the functional outcome of SI. In moderately
selective and nonselective proteinuria, the remission rateevaluate its predictive value on functional outcome and
response to therapy, either when considered alone or in was 62 versus 6% according to the FE a1m values below
or above the cutoffs (P 5 0.0001), and the CRF rate wascombination with a marker of tubular damage, such as
the fractional urinary excretion of a protein of LMW 7 versus 69% according to the FE a1m values (P 5
0.0001). Finally, the rate of response to therapy wassuch as a1-m. Our study of 89 patients with nephrotic
syndrome caused by MCD, FSGS, and MGN showed influenced by selectivity of proteinuria and fractional
excretion of a1m. The response rate to treatment wasthat a significant relationship exists between the selectiv-
ity of proteinuria and the degree of tubulointerstitial 100% in highly selective proteinuria, 67% in moderately
selective, and 33% in nonselective proteinuria (P 5damage. Nonselective proteinuria is significantly associ-
ated with diffuse tubulointerstitial damage (P 5 0.000), 0.0002) and was 75 versus 10% in moderately selective
and in nonselective proteinuria according to FE a1mwith the SDS-PAGE pattern characterized by a more
severe tubular component of proteinuria, the so-called values (P 5 0.001). Very similar results were obtained
if eight patients whose renal biopsy was performed 88 6 5510 kD pattern (P 5 0.000), and with fractional excretion
of a1m above some defined cutoffs (P 5 0.000). Patients months before the characterization of proteinuria were
excluded from the follow-up study, thus limiting the sta-with highly and moderately selective proteinuria, although
not different for mean values of SCr, 24-hour proteinuria tistical analysis to 52 patients who had the start of follow-
up at renal biopsy.and rates of diffuse tubulointerstitial damage (15 vs. 17%),
are on the contrary different for the rate of the 10 kD From these data, several conclusions can be drawn.
The degree of selectivity of proteinuria, expressed aspattern (13% vs. 36%) and FE a1m above the cutoffs (13
vs. 24%). This observation suggests that the qualitative the clearance of IgG over clearance of transferrin, is a
reliable indicator of the severity and reversibility of theevaluation of proteinuria by SDS-PAGE or the quantita-
tive calculation of fractional excretion of a1m as marker abnormalities of glomerular permeability. The presence
of highly selective proteinuria, although characterizedof reabsorption impairment of LMW proteins is a more
sensitive methods for assessing tubular damage than by overall protein loss not significantly different from
moderately selective and nonselective proteinuria, re-standard histologic methods.
The selectivity of proteinuria shows a significant rela- flects a less severe lesion, rarely associated with tubuloin-
terstitial damage and conversely associated with 100%tionship with the functional outcome, particularly if con-
sidered in combination with the fractional excretion of of clinical remission, spontaneous (in 5 of 7 MGN pa-
tients) or in response to therapy (in MCD and FSGS).a1m. In 60 patients with baseline NRF, partial or com-
plete clinical remission developed in 100% of patients The other two degrees of selectivity (moderately selec-
tive and nonselective), although not different from highlywith highly selective proteinuria, 50% of patients with
moderately selective proteinuria, and 29% of patients selective proteinuria in terms of total 24-hour protein
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loss, are associated with different severity of the tubulo- lesions, as suggested by the lack of these lesions in MCD,
interstitial damage and different rates of remission or notwithstanding high values of proteinuria.
progression to CRF. Thus, it seems that when proteinuria In conclusion, the characterization of some qualitative
is highly selective, the tubulointerstitial involvement is aspects of proteinuria (selectivity, severity of the “tubu-
absent or very mild, the functional outcome is excellent lar” component of proteinuria) is useful in identifying
and influenced only by the lesions of the glomerular in the single patient the degree of the damage that takes
capillary wall. When the proteinuria is moderately selec- place in the glomerular and tubulointerstitial compart-
tive or nonselective, increasing numbers of patients de- ments of the nephron, giving much more information
velop tubulointerstitial lesions, and the functional out- than the simple measurement of 24-hour proteinuria.
come is increasingly worse and dependent not only on The combination of the two markers of glomerular and
the lesions of glomerular capillary wall, but also or tubulointerstitial damage (SI and fractional excretion of
largely on those that take place in the tubulointerstitial a1m) shows a very high predictive value on functional
compartment, as demonstrated by the observation that outcome and response to therapy, predicting clinical re-
the FE a1m, if exceeding some defined cutoffs, enhances mission in up to 100% and progression to CRF in up to
the predictive value of SI, decreasing the rates of remis- 57 to 78% of individuals. This high predictive value may
sion and response to therapy and increasing the rates of consistently reduce the unpredictability of the outcome
progression to CRF, which attains percentages of 57% of the single patient and may be useful in orienting the
(FSGS) and 78% (MGN). starting time, type, and duration of therapy.
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